ZAP

This brand name is authorized in Canada, New Zealand.

Active ingredients

The drug ZAP contains a combination of these active pharmaceutical ingredients (APIs):

1	Benzocaine UNII U3RSY48JW5 - BENZOCAINE
	Benzocaine is a local anaesthetic of the ester type, acting to produce reversible loss of sensation by preventing or diminishing the generation and transmission of sensory nerve impulses near the site of application. Depolarisation of the neuronal membrane and ion exchange are reversibly inhibited.
	Read more about Benzocaine
2	Tetracaine UNII 5NF5D4OPCI - TETRACAINE HYDROCHLORIDE
	Tetracaine is a local anaesthetic and is believed to act by blocking nerve conduction mainly by inhibiting sodium ion flux across the axon membrane.
	Read more about Tetracaine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D04AB04	Benzocaine	D Dermatologicals → D04 Antipruritics, incl. antihistamines, anesthetics, etc. → D04A Antipruritics, incl. antihistamines, anesthetics, etc. → D04AB Anesthetics for topical use
Discover more medicines within D04AB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	01930699
NZ	Medicines and Medical Devices Safety Authority	12368